Two concurrent mutational signatures in CSF3R (Colony Stimulating Factor 3 Receptor) and CEBPA (CCAAT Enhancer Binding Protein Alpha) that are related to higher relapse rates have been identified in patients with acute myeloid leukemia. Here, CSF3R is linked to acute myeloid leukemia.